TLR9 and neoplasm: We performed a comprehensive analysis of tumor-infiltrating immune cells in a cohort of intrahepatic and extrahepatic BTC, including innate immunity members such as TLR7, TLR9, and adaptive immunity factors such as CD4 and CD8 as well as PD-1 and PD-L1 expression at protein level.